SCHEMBL2215145

SCHEMBL2215145

CC(C)(C)OC(=O)Nc1ccc(Nc2nc(-c3cccc4c3oc3ccccc34)cc3ccnn23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.36
TDP2 O95551 2/20 0.36
TOP2A P11388 1/20 0.35
TOP2B Q02880 1/20 0.35
ACSS2 Q9NR19 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA9 Q16790 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
HSD17B10 Q99714 1/20 0.35
AURKA O14965 1/20 0.34
AURKB Q96GD4 1/20 0.34
NAMPT P43490 2/20 0.34
TLR7 Q9NYK1 1/20 0.33
PSMB8 P28062 1/20 0.33
CHRM1 P11229 1/20 0.33
CCKBR P32239 1/20 0.33
CDK1 P06493 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2212145 0.94 BRD4 (0.39) BRD4TDP2TOP2ATOP2BACSS2
SCHEMBL2213364 0.88 NAMPT (0.36) BRD4POLBMAPTNAMPTCCKBR
SCHEMBL2214698 0.87 BRD4 (0.38) BRD4MAPTNAMPTCCKBR
SCHEMBL2213218 0.85 TRPV1 (0.42) ALDH1A1MAPTHSD17B10NAMPT
SCHEMBL2216183 0.85 ALDH1A1 (0.42) ALDH1A1POLBMAPTHSD17B10AURKA
SCHEMBL2215529 0.84 ALDH1A1 (0.38) ALDH1A1POLBMAPTHSD17B10AURKA
SCHEMBL2214770 0.84 NAMPT (0.34) BRD4ALDH1A1MAPTHSD17B10NAMPT
SCHEMBL2215331 0.83 SRC (0.33) ALDH1A1AURKBCDK1
SCHEMBL2215080 0.83 LMNA (0.50) ALDH1A1POLBMAPTHSD17B10NAMPT
SCHEMBL2884113 0.83 SMN1; SMN2 (0.37) ALDH1A1POLBMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1797096-B1 PYRAZOLOPYRIMIDINES AS INHIBITORS OF PROTEIN KINASE B (AKT) BAYER SCHERING PHARMA AG (DE) 2011-07-27 EP disclosed